Inhibikase Therapeutics Inc (NASDAQ: IKT)

What Are Analyst Opinions Regarding Inhibikase Therapeutics Inc (IKT)?

Cody Benson

Inhibikase Therapeutics Inc (IKT) saw an uptrend of 1.21% in the recent trading with $1.67 being its most recent. The ...

Inhibikase Therapeutics Inc (IKT): The long term indicators on the stock call for a Buy today

Noah Smith

Inhibikase Therapeutics Inc (IKT) saw an uptrend of 4.06% in the recent trading with $2.05 being its most recent. The ...

Inhibikase Therapeutics Inc (IKT):Sell today, is the recommendation of the stock’s medium term indicators

Heidi Phillips

Inhibikase Therapeutics Inc (IKT) saw an uptrend of 3.77% in the recent trading with $1.65 being its most recent. The ...

Baxter Report
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.